- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Nat Turner: Data Can Disrupt Clinical Research and Improve Patient Care
Nat Turner, co-founder and CEO of Flatiron Health, explains how data can be used for finding potential patients to be included in clinical trials.
Nat Turner, co-founder and CEO of Flatiron Health, explains how data can be used for finding potential patients to be included in clinical trials.
Transcript (slightly modified)
How is data being used in clinical research to improve patient care?
A bunch of ways. The easiest to understand, or the simplest, is finding patients. So, you might have 800 patients coming in across your clinical in a day, you need to figure out which of those—most won’t be eligible—are potentially eligible for a clinical trial. Data is really the best way to do that since you can do it even before the patient walks in the door. That’s what we call patient finding.
The next is feasibility. So, if you’re a site and maybe you attract a certain type of patient population, maybe a doctor of yours specializes—whatever it might be—showing off your patient population to sponsors that are running trials is a very data-driven opportunity that could help you attract better studies. Also, once the study is live there’s a lot of data that could be used. Today, for example, you’re trying to compare a treatment to the real world, the standard of care, perhaps you could use the electronic health record data to model that standard of care, so you don’t have patients that could go on placebo, you could just model the standard of care. That’s a really exciting way data could disrupt clinical research.
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
What We’re Reading: ChatGPT in Health Care; Menthol Ban Meeting; Health System Cyberattack Impact
November 30th 2023ChatGPT is changing health care while also raising questions about artificial intelligence's promises and limitations; 24 Biden officials met with the National Organization of Black Law Enforcement Executives to discuss the FDA’s proposal to ban menthol cigarettes; a recent hospital cyberattack shows how the vulnerability of health care systems can put patients at risk.
Read More
7-Day Dosing of Azacytidine Shows Benefit for Females With High-Risk MDS Not Seen in Males
November 30th 2023Investigators from several medical centers in Japan were surprised to find that women with myelodysplastic syndrome (MDS) had a survival advantage from a 7-day dosing schedule, but that benefit compared with a reduced schedule was not seen in men.
Read More
